Biomedical Research

Reference 34 - Immediate Adverse Reactions to Gandolinium-Based MR Contrast Media

Reference 35 - The Impact of Gadolinium on Quantitative Myelin Metrics

Reference 36 - Effects of gadolinium

Reference 37 - Gadolinium Contrast Agent Deposition in Children

Reference 38 - Ultrastructural Evidence of Dermal Gadolinium Deposits

Reference 39 - Delineating toxicity mechanisms associated with MRI contrast

Reference 40 - The involvement of proinflammatory cytokines in nephrogenic systemic fibrosis

Reference 41 - Long-Term Treatment with Gadopentetic Acid or Gadodiamide

Reference 42 - Altered Functional Mitochondrial Protein Levels in Plasma

Reference 43 - An initial investigation of serum cytokine levels in patients with gadolinium retention

Citizen Petition from Earthjustice, et. al.

Acknowledgment Letter from FDA DMB to Earthjustice, et. al.